GSE160018
Adaptive responses of the HER2+ SKBR-3 and BT474m1 cell lines to lapatinib and JQ1
SKBR-3 or BT474m1 HER2+ breast cancer cells were treated with either DMSO, 300nM lapatinib, 300nM JQ1, or lapatinib and JQ1 in combination for 48h. Overall design: 8 experimental samples